My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

AbbVie (NY:ABBV)

214.35 -0.67 (-0.31%)

Official Closing Price Updated: 7:00 PM EST, Jan 16, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about AbbVie

< Previous 1 2

...

9 10 11 12 13 14 15 16 17

...

92 93 Next >

U.S. Pharmaceutical Imports Might Soon Face Tariffs: 3 Stocks That Could Tumble as a Result ↗

May 24, 2025

There's little doubt these pharmaceutical companies' costs will soon be rising at least a little.

Via The Motley Fool

Elon Musk Commits to Tesla. Is That a Good Thing? ↗

May 23, 2025

Via The Motley Fool

2 Incredible Dividend Growth Stocks to Buy Now ↗

May 21, 2025

Via The Motley Fool

Topics Government Intellectual Property

10 Health Care Stocks With Whale Alerts In Today's Session ↗

May 20, 2025

Via Benzinga

A Look Into AbbVie Inc's Price Over Earnings ↗

May 13, 2025

Via Benzinga

What Does the Market Think About AbbVie? ↗

May 13, 2025

Via Benzinga

Don't Fall for These 3 Dividend Stocks: They May Have to Make a Cut. ↗

May 18, 2025

Here are three dividend-paying stocks that warrant closer examination.

Via The Motley Fool

3 Magnificent Stocks That Are Passive Income Machines ↗

May 17, 2025

Via The Motley Fool

3 Stocks That Will Profit From Trump's Drug Price Cut ↗

May 16, 2025

Trump's EO aims to lower US drug prices by using leverage of public programs (like Medicare) to force accountability. Big pharma may be hit hardest.

Via Benzinga

Topics Government

1 Healthcare Stock to Keep an Eye On and 2 to Ignore

May 16, 2025

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory...

Via StockStory

Topics Economy Stocks

AbbVie Unusual Options Activity ↗

May 12, 2025

Via Benzinga

Why Pfizer Is Poised For A Strong Comeback: My Top Pick For 2025 ↗

May 15, 2025

For investors willing to look beyond the current negative sentiment, Pfizer at today's prices represents a rare buying opportunity.

Via Benzinga

Jim Cramer Says Even 'Safety' Stocks Look Risky, Warns Of 'Wild Card' In Washington And Rising Treasury Yields As Reasons To Stay Away From Sure Bets ↗

May 15, 2025

Rising bond yields and uncertain politics make 'safety' stocks less appealing, says Jim Cramer. Even Procter & Gamble and Johnson & Johnson suddenly feel shaky to the market guru.

Via Benzinga

Topics Bonds

Stay informed with the top movers within the S&P500 index on Wednesday. ↗

May 14, 2025

Join us in exploring the top gainers and losers within the S&P500 index one hour before the close of the markets on Wednesday as we examine the latest happenings in today's session.

Via Chartmill

FDA Fast-Tracks AbbVie's New Lung Cancer Therapy Emrelis For Tough Lung Cancer Cases ↗

May 14, 2025

FDA grants accelerated approval to AbbVie's Emrelis for c-Met overexpressing NSCLC; siRNA partnership with ADARx includes $335 million upfront.

Via Benzinga

AbbVie Gets FDA Nod For Drug To Treat Lung Cancer: Retail’s Yet To React ↗

May 14, 2025

The company also announced a collaboration and license option agreement with ADARx Pharmaceuticals to develop small interfering RNA (siRNA) therapeutics across multiple disease areas, including...

Via Stocktwits

What's going on in today's session: S&P500 movers ↗

May 14, 2025

Curious about the top performers within the S&P500 index in the middle of the day on Wednesday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.

Via Chartmill

Expert Outlook: AbbVie Through The Eyes Of 10 Analysts ↗

May 14, 2025

Via Benzinga

Q1 Therapeutics Earnings: United Therapeutics (NASDAQ:UTHR) Impresses

May 13, 2025

As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the therapeutics industry, including United Therapeutics (NASDAQ:UTHR) and its peers.

Via StockStory

Topics Artificial Intelligence

Congressional Trading Report: Rep. Jared Moskowitz Bought Over $27K In AbbVie Stock ↗

May 12, 2025

Via Benzinga

Top S&P500 movers in Monday's pre-market session ↗

May 12, 2025

Stay updated with the S&P500 stocks that are on the move in today's pre-market session.

Via Chartmill

S&P 500, Dow Jones Pharma Stocks Boomerang As Trump Threatens Drug-Price Reform ↗

May 12, 2025

It's still unclear how President Donald Trump plans to tie drug prices in the U.S. to international prices.

Via Investor's Business Daily

Topics Government Stocks

Wall Street Rips Higher As Tariff Truce Halts US–China Economic Escalation ↗

May 12, 2025

US-China agree to slash tariffs by over 100%, easing fears of economic slowdown and inflation. Markets cheer with futures rising and yields up.

Via Benzinga

Topics Economy World Trade

Recession Worries? Here's 1 of the Best Dividend Stocks for Turbulent Times ↗

May 11, 2025

Via The Motley Fool

Topics Economy World Trade

2 High-Yield Dividend Stocks to Buy in May and Hold Forever ↗

May 10, 2025

Via The Motley Fool

Topics Intellectual Property

10 Health Care Stocks With Whale Alerts In Today's Session ↗

May 09, 2025

Via Benzinga

Recent Report Shows That Rep. Jefferson Shreve Bought Up to $4.75M Worth of Apple Stock ↗

May 09, 2025

Via Benzinga

Thursday's session: gap up and gap down stock in the S&P500 index ↗

May 08, 2025

Curious about the market action on Thursday? Dive into the US markets to explore the gap up and gap down stocks in the S&P500 index during today's session.

Via Chartmill

Q1 Earnings Recap: AbbVie (NYSE:ABBV) Tops Therapeutics Stocks

May 07, 2025

Let’s dig into the relative performance of AbbVie (NYSE:ABBV) and its peers as we unravel the now-completed Q1 therapeutics earnings season.

Via StockStory

Topics Artificial Intelligence

Marjorie Taylor Greene Goes Stock Shopping Again: Here Are 50+ Stocks The Congresswoman Bought ↗

May 07, 2025

Marjorie Taylor Greene disclosed buying more than 50 stocks in early May. A look at the list and why the congresswoman's past trades have drawn red flags.

Via Benzinga

< Previous 1 2

...

9 10 11 12 13 14 15 16 17

...

92 93 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.